The Real Test for the NHS Federated Data Platform

Billions of pounds. One platform. One supplier.

The debate around the Federated Data Platform and Palantir has gone on for a while now, and rightly so. A programme of this scale, backed by public money and tied so closely to one supplier, should absolutely be challenged and scrutinised.

And honestly, I still think one of the biggest unanswered questions is: how do we know if this is genuinely delivering value?

The conversation sometimes gets stuck on procurement.

Whether people agree or disagree with the supplier choice, the reality is the platform is here now. Organisations are already implementing it.

So the bigger questions become: What does success actually look like from this point onwards? Is the platform genuinely helping operational teams make better decisions? Is it reducing duplication? Will clinicians actually feel the benefit in day-to-day practice?

I’ve seen enough large digital programmes across healthcare to know that “implemented” and “working well” are two very different things.

A dashboard existing doesn’t automatically mean better decisions are being made. A platform being rolled out doesn’t mean behaviours, processes, or confidence have changed alongside it.

And I think this is where assurance becomes really important, not just as governance paperwork, but as an ongoing discipline throughout delivery.

We should be asking ourselves whether we are measuring meaningful outcomes consistently, being honest when adoption is low or value isn’t materialising, and making sure organisations actually have the capability and support around them to embed this properly.

Because in a system as complex as the NHS, technology on its own rarely solves the problem.

Personally, I think there’s also a bigger role here for independent delivery partners. People who sit close enough to delivery to understand reality on the ground, but independent enough to challenge whether outcomes are actually being achieved.

That’s something we think about a lot at Avencera.

Not just helping organisations deliver transformation, but helping them stay focused on whether the change is genuinely landing and creating value in practice.

The FDP absolutely has potential. The NHS clearly needs better connected data and less fragmentation.

But the real test won’t be whether the platform went live.

It’ll be whether, in a few years’ time, frontline teams genuinely feel healthcare works better because of it.